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ABSTRACT
Background
Sleep duration may be an important regulator of body weight and metabolism. An
association between short habitual sleep time and increased body mass index (BMI) has been
reported in large population samples. The potential role of metabolic hormones in this
association is unknown.
Methods and Findings
Study participants were 1,024 volunteers from the Wisconsin Sleep Cohort Study, a
population-based longitudinal study of sleep disorders. Participants underwent nocturnal
polysomnography and reported on their sleep habits through questionnaires and sleep diaries.
Following polysomnography, morning, fasted blood samples were evaluated for serum leptin
and ghrelin (two key opposing hormones in appetite regulation), adiponectin, insulin, glucose,
and lipid profile. Relationships among these measures, BMI, and sleep duration (habitual and
immediately prior to blood sampling) were examined using multiple variable regressions with
control for confounding factors.
A U-shaped curvilinear association between sleep duration and BMI was observed. In persons
sleeping less than 8 h (74.4% of the sample), increased BMI was proportional to decreased
sleep. Short sleep was associated with low leptin (p for slope = 0.01), with a predicted 15.5%
lower leptin for habitual sleep of 5 h versus 8 h, and high ghrelin (p for slope = 0.008), with a
predicted 14.9% higher ghrelin for nocturnal (polysomnographic) sleep of 5 h versus 8 h,
independent of BMI.
Conclusion
Participants with short sleep had reduced leptin and elevated ghrelin. These differences in
leptin and ghrelin are likely to increase appetite, possibly explaining the increased BMI
observed with short sleep duration. In Western societies, where chronic sleep restriction is
common and food is widely available, changes in appetite regulatory hormones with sleep
curtailment may contribute to obesity.
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In population studies, a dose-response relationship be-
tween short sleep duration and high body mass index (BMI)
has been reported across all age groups [1–7]. In the largest
studied sample, elevated BMI occurred for habitual sleep
amounts below 7–8 h [2]. A U-shaped curvilinear relationship
between sleep duration and BMI was observed for women,
but for men, there was a monotonic trend towards higher
BMI with shorter sleep duration. Importantly, a recent
prospective study identiﬁed a longitudinal association be-
tween sleep curtailment and future weight gain [6]. How sleep
curtailment may interact with body weight is unknown, but
hormones regulating appetite and energy expenditure may
be involved.
A number of hormones may mediate the interactions
between short sleep duration, metabolism, and high BMI. We
hypothesized that the two key opposing hormones in appetite
regulation, leptin and ghrelin [8,9], play a signiﬁcant role in
the interaction between short sleep duration and high BMI.
Leptin is an adipocyte-derived hormone that suppresses
appetite [10]. Ghrelin is predominantly a stomach-derived
peptide that stimulates appetite [9,11]. Other mediators of
metabolism that may contribute include adiponectin and
insulin. Adiponectin is a novel hormone secreted by
adipocytes and is associated with insulin sensitivity [12,13].
We investigated the associations among sleep duration (acute
and habitual), metabolic hormones, and BMI in the popula-
tion-based Wisconsin Sleep Cohort Study [14].
Methods
Overview
The institutional review board of the University of
Wisconsin Medical School approved all protocols for the
study, and informed consent was obtained from all partic-
ipants. The Wisconsin Sleep Cohort Study is an ongoing
longitudinal study of sleep habits and disorders in the general
population [14]. Brieﬂy, to construct a deﬁned sampling
frame, all employees aged 30–60 y of four state agencies in
south central Wisconsin were mailed a survey on sleep habits,
health, and demographics in 1989. Mailed surveys were
repeated at 5-y intervals. A stratiﬁed random sample of
respondents was then recruited for an extensive overnight
protocol including polysomnography at baseline. Stratiﬁca-
tion was based on risk for sleep-disordered breathing (SDB),
with an oversampling of habitual snorers to ensure an
adequate distribution of SDB. Analyses were adjusted for
the weighted sampling when appropriate. Recruitment for
baseline studies was staggered to conduct seven studies per
week; study entry and follow-up time thus varied within the
cohort. Exclusion criteria included pregnancy, unstable
cardiopulmonary disease, airway cancers, and recent upper
respiratory tract surgery. The baseline response rate was
51%, with most refusals due to the inconvenience of sleeping
away from home. Follow-up studies have been conducted at
4-y intervals, with up to three follow-up studies to date.
Collection of morning, fasted blood was added to the
protocol in 1995. Extensive survey and other data available
from the sampling frame have been used to evaluate the
potential for response and drop out biases.
Figure 1 provides an overview of the study population and
the data collected. The sample comprised 1,024 participants
with an overnight study and blood sample. A 6-d diary of
sleep duration was added as part of a protocol to assess
daytime sleepiness after the initiation of the cohort study;
these data were available for 721 participants.
Data Collection
This investigation is based on Wisconsin Sleep Cohort
Study data collected from the mailed sleep surveys, overnight
studies, and 6-d sleep diaries. Overnight studies were
conducted in laboratory bedrooms, with participants setting
their own sleep and rise times. After informed consent was
obtained, questionnaires on lifestyle and health history were
administered, and height and weight measured. A blood
sample was collected shortly after awakening from overnight
polysomnography.
Polysomnography. An 18-channel polysomnographic sys-
tem was used to assess sleep states, and respiratory and cardiac
variables [14]. Sleep was studied using electroencephalogra-
phy, electro-oculography, and chin electromyography (Grass
Instruments, Quincy, Massachusetts, United States). Continu-
ous measurement of arterial oxyhemoglobin saturation by
pulse oximetry (Ohmeda, Englewood, Colorado, United
States), oral and nasal airﬂow, nasal air pressure, and thoracic
cage and abdominal respiratory motion (Respitrace Ambula-
tory Monitoring, Ardsley, New York, United States) were used
to assess SDB [14]. Each 30-s interval of the polysomnographic
record was scored for sleep stage and SDB using standard
criteria [14]. The average number of apneas and hypopneas
per hour of measured sleep, the apnea-hypopnea index (AHI),
was the measure for SDB. For analyses including AHI as a
Figure 1. Sample Construction and Data Collected
All employees (aged 30–60 y) of four state agencies in south central
Wisconsin were mailed surveys starting in 1989 regarding general
health and sleep habits. From this population, a stratiﬁed random
sample of respondents was recruited for an extensive overnight
protocol providing polysomnography and sleep questionnaire data
and morning, fasted serum for hormone and metabolite measure-
ment. The metabolic hormones measured were ghrelin (856
participants), leptin (1,017 participants), adiponectin (1,015 partic-
ipants), and insulin (1,014 participants) (see Table 1). Based on
scheduling availability, 721 participants completed an added protocol
to measure daytime sleepiness that included a 6-d sleep diary, of
which 714 reported on naps (see Table 1). See text for further
description of the study population and deﬁnitions of the sleep
measures used.
DOI: 10.1371/journal.pmed.0010062.g001
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Leptin, Ghrelin, and Sleepcovariate, participants were excluded if they had sleep studies
with less than 4 h of usable polysomnography, or if they were
receiving treatment for SDB.
Polysomnographic measures of acute sleep. Polysomno-
graphic measures of sleep duration just prior to blood
sampling were used to evaluate degree of ‘‘acute sleep
restriction.’’ ‘‘Total sleep time’’ was total hours of polysomno-
graphically deﬁned sleep. ‘‘Wake after sleep onset’’ (WASO)
was hours of wake time after three epochs of sleep had
occurred. ‘‘Sleep efﬁciency’’ was total sleep time divided by
time from lights out until arising in the morning.
Self-reported sleep measures of chronic sleep. Two
variables were used to evaluate degree of ‘‘chronic sleep
restriction’’ by estimating average nightly sleep duration: (i)
‘‘usual sleep’’ (from questionnaires) and (ii) ‘‘average nightly
sleep’’ (from sleep diaries).
Questionnaire. Usual sleep was estimated from the follow-
ing questions: how many hours of sleep do you usually get in
(a) a workday night? (b) a weekend or non-work night? These
questions were included in all mailed surveys and were added
to questionnaires completed at the overnight study in 1998.
For participants studied after 1998, data from questionnaires
administered at the overnight study were used (58%); for the
remainder of the sample, data from the mailed survey closest
in time to the overnight study were used. Usual sleep was
calculated as (5 3 workday sleep þ 2 3 weekend sleep)/7.
Sleep diary. Average sleep duration was also estimated
using a 6-d sleep diary, kept by 721 participants as part of an
added protocol to measure daytime sleepiness. The median
time between the blood collection and completion of the
diary was 18 d. Almost all diaries (97%) were completed
within 6 mo of blood sampling. In diaries, participants
recorded the time they went to bed and arose each day, and
the duration of any naps. ‘‘Average nightly sleep’’ was
calculated as the sum of the hours between bedtime and
arising divided by six. ‘‘Average nightly sleep plus naps’’
added naps to the above sum.
The Relationship between BMI and Sleep Duration
For the analysis of the association of BMI and sleep
duration, the sample comprised 1,040 participants with at
least one 6-d sleep diary. Of these, 4-, 8-, and 12-y follow-up
studies had been completed by 397, 179, and 11 participants
respectively (1,828 visits), providing repeated measures data
for greater analytic efﬁciency and precision.
Hormone Assays
Following overnight fasting, serum was collected soon after
awakening and stored at  70 8C. All samples were assayed in
duplicate. It was not possible to assay samples from all
participants in all assays because of the volume of serum
available; this particularly affected the ghrelin assay, which
required the most volume. Leptin and insulin were deter-
mined using enzyme-linked immunoassays (ELISA; Linco
Research, St. Charles, Missouri, United States). Total ghrelin
and adiponectin were measured by radioimmunoassay (Linco
Research). Sensitivity for the leptin and insulin enzyme-
linked immunoassays was 0.5 ng/ml and 2 lU/ml, respectively.
Sensitivity for the ghrelin and adiponectin radioimmuno-
assays was 10 pg/ml and 1 ng/ml, respectively. Intra- and inter-
assay variations were all less than 5% and less than 10%,
respectively. The quantitative insulin sensitivity check index
(QUICKI) was 1/(log (I)þlog (G)), where I is fasting insulin and
G is fasting glucose [15,16].
Statistical Analysis
All analyses were cross-sectional and performed using SAS/
STAT 8.2. Leptin, ghrelin, and adiponectin were square-root
transformed and insulin log transformed based on the
distribution of residuals from the multivariate regression
models. We evaluated the relationship of age, sex, BMI, and
time of storage of blood sample on hormones using multiple
regression. Partial correlations adjusted for age, sex, and BMI
were calculated for hormones and QUICKI, with and without
control of other potential confounders. The relationships
between hormones and sleep were evaluated using multiple
linear regression after control for potential confounders
including age, sex, BMI, SDB, and morningness tendencies (as
measured using the Horne-Ostberg questionnaire, an indi-
rect surrogate of earlier rising time). In all analyses involving
insulin, glucose, and QUICKI (but not leptin, ghrelin, and
adiponectin), participants with diabetes (self-reported diag-
nosis, or currently taking insulin or diabetic medications, or
with glucose .300 mg/dl) were excluded. Participants with
SDB were not removed from the analyses shown. When
controlling for AHI in models, participants who used
continuous positive airway pressure or who had inadequate
sleep were excluded. Because controlling for AHI did not
signiﬁcantly change the sleep-hormone regression coefﬁ-
cients, these analyses are not shown. The relationship of BMI
with average nightly sleep was evaluated using a quadratic ﬁt.
This was examined using multiple visits (n=1,828) from
1,040 participants with sleep diary data available. Mixed
modeling techniques were used to account for within-subject
correlation for participants with multiple visits. SAS proce-
dure mixed was used for modeling and hypothesis testing
using robust standard errors and a compound symmetric
within-subject correlation structure. All reported p values are
two-sided. For illustrative purposes, changes in leptin,
ghrelin, and BMI for different sleep amounts were calculated
at the average values and sex distribution of the relevant
sample.
Results
Table 1 shows the characteristics of the sample, unadjusted
for the weighted sampling scheme. Figure 2 shows the mean
BMI for 45-min intervals of average nightly sleep after
adjustment for age and sex. We found a signiﬁcant U-shaped
curvilinear relationship between average nightly sleep and
BMI after adjustment for age and sex (average nightly sleep
coefﬁcient =  2.40, p=0.008; (average nightly sleep)
2
coefﬁcient = 0.156, p=0.008; the two coefﬁcients deﬁne a
curve). The minimum BMI was predicted at 7.7 h of average
nightly sleep. The most striking portion of the curve was for
persons sleeping less than 8 h (74.4% of the sample), where
increased BMI was proportional to decreased sleep. An
increase in BMI from 31.3 to 32.4 (þ3.6%) corresponded
approximately to an average nightly sleep duration decrease
from 8 h to 5 h, as estimated at the mean age (53.1 y) and sex
distribution (54.4% male) of the sample with available sleep
diary data.
Table 2 shows the association of each of the hormones,
glucose, and QUICKI with age, sex, and BMI. Serum ghrelin,
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correlated with BMI and sex. Storage time had signiﬁcant
effects on some but not all variables; in all cases, however,
effect size was small, and the effect was corrected for in all
calculations. Adiponectin and glucose were correlated with
age. Table 3 shows partial correlations among the measured
and calculated variables, adjusted for age, sex, and BMI. All
correlations agree with previous studies and validate our
assays and population sample. We also examined several
potential confounders to be later controlled for, if needed, in
our models. Identiﬁed relationships included: ghrelin with
high-density lipoprotein (HDL), alcohol intake, and creati-
nine; leptin with diastolic blood pressure, smoking, and blood
urea nitrogen (BUN); adiponectin with HDL, triglycerides,
uric acid, and BUN; insulin with HDL, triglycerides, uric acid,
and smoking; glucose with HDL, triglycerides, uric acid,
alcohol intake, BUN, and creatinine; QUICKI with HDL,
triglycerides, uric acid, smoking, and BUN. When diabetics
(diagnosed) and participants with high glucose (glucose .300
mg/dl) were removed from this analysis, all relationships
remained signiﬁcant except for the correlation between
ghrelin and adiponectin, and ghrelin and insulin.
Using polysomnography to measure objective sleep imme-
diately prior to blood sampling, ghrelin correlated signiﬁ-
cantly with total sleep time, sleep efﬁciency, and WASO
(Table 4). Using questionnaire and diary data estimating
chronic sleep, signiﬁcant correlations were found between
leptin and average nightly sleep (with and without naps) and
usual sleep amounts (Table 4). A signiﬁcant correlation was
also observed between ghrelin and average nightly sleep plus
naps. These relationships were consistently found when other
possible confounding factors such as medications, hyper-
tension, AHI, and factors listed above were included in the
statistical model (analysis not shown). In unadjusted models,
leptin was signiﬁcantly correlated with total sleep time and
average weekly sleep with naps, and ghrelin was signiﬁcantly
correlated with sleep efﬁciency and WASO. Figure 3A shows
the mean leptin levels for half-hour increments of average
nightly sleep after adjustment for age, sex, BMI, and time of
storage (see Table 2). In the multiple regression model (see
Table 4), there was a signiﬁcant increasing trend in leptin for
average nightly sleep duration (p=0.01). When evaluated at
the average values and sex distribution of our sample, a
decrease from 8 to 5 h in average nightly sleep was associated
with a predicted 15.5% decrease in leptin. Figure 3B shows
the mean ghrelin levels for half-hour increments of total
sleep time after adjustment for age, sex, BMI, and time of
storage (see Table 2). In the multiple regression model (see
Table 1. Characteristics of the Sample
Category Variable Mean (Standard Deviation) Sample Size (Percent)
General Age (years) 52.7 (8.2)
Male 551 (53.8%)
BMI (kg/m
2) 29.7 (26.2, 34.7)
a
Sleep duration variables Polysomnography-derived:
Total sleep time (hours) 6.2 (1.1)
Sleep efficiency (proportion) 0.82 (0.11)
WASO (hours) 1.1 (0.71)
Self-reported:
Usual sleep (hours) 7.2 (0.99, n=1,023)
Average nightly sleep (hours) 7.5 (0.91, n=721)
Average nightly sleep with naps (hours) 7.7 (0.94, n=714)
Hormones Ghrelin (pg/ml) 968.8 (558.8, n=856)
Leptin (ng/ml) 19.9 (19.3, n=1,017)
Adiponectin (ng/ml) 16.8 (9.9, n=1,015)
Insulin (lU/ml) 13.2 (10.6, n=1,014)
Metabolites Glucose (mg/dl) 100.8 (26.6, n=1,023)
Total cholesterol (mg/dl) 204.6 (36.9, n=1,023)
HDL (mg/dl) 48.3 (14.5, n=1,023)
LDL (mg/dl) 126.3 (32.1, n=1,001)
Triglycerides (mg/dl) 151.2 (94.8, n=1,022)
QUICKI 0.34 (0.04, n=974)
Medical conditions Hypertension 404 (39.5%, n=1,023)
Diabetes 78 (7.6%, n=1,023)
Medication use Antidepressants 171 (16.7%)
Anti-hypertensives 286 (27.9%)
Anti-inflammatories 285 (27.8%)
Cholesterol-lowering medications 143 (14.0%)
Insulin or oral diabetes medications 61 (6.0%)
Estrogen or oral contraceptives 135 (13.2%)
Lifestyle traits Night or rotating shift work 39 (6.4%, n = 611)
Current smoking 134 (13.1%, n=1,023)
Alcoholic drinks per week 3.6 (5.0, n=1,023)
Other sleep data Horne-Ostberg score 61.7 (9.7, n=628)
AHI 2.6 (0.6, 9.3)
a
n=1,024 except as noted.
a Median (first quartile, third quartile).
LDL, low-density lipoprotein.
DOI: 10.1371/journal.pmed.0010062.t001
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with total sleep time (p=0.008). When evaluated at the
average values and sex distribution of our sample, a decrease
from 8 to 5 h of polysomnographically deﬁned total sleep
time was associated with a predicted 14.9% increase in
ghrelin. There was no signiﬁcant correlation between sleep
duration (acute or chronic) and serum adiponectin, insulin,
glucose, or QUICKI. Results of our analyses were unchanged
after adjusting for the weighted sampling scheme.
Discussion
We found that habitual sleep duration below 7.7 h was
associated with increased BMI, similar to ﬁndings in other
studies including children [1,17], adolescents [5], and adults
[2,3]. We also report a signiﬁcant association of sleep
duration with leptin and ghrelin that is independent of
BMI, age, sex, SDB, and other possible confounding factors
(analysis not shown for SDB and other confounders). Short
sleep duration was associated with decreased leptin and
increased ghrelin, changes that have also been observed in
reaction to food restriction and weight loss and are typically
associated with increased appetite. These hormone alter-
ations may contribute to the BMI increase that occurs with
sleep curtailment.
Previous studies have shown that both acute sleep
deprivation [18] and chronic partial sleep deprivation (sleep
restriction) [19] can cause a decrease in serum leptin
concentrations. These studies, however, were performed
under highly controlled laboratory circumstances. Our
results validate the association of decreased leptin with
decreased sleep time in a large sample of adults under real-
life conditions and, now, indicate a role for ghrelin. Leptin
deﬁciency increases appetite and produces obesity [8,20].
Leptin administration suppresses food intake and reduces
energy expenditure [21,22]. Importantly, low leptin as
observed with sleep loss has a greater impact on appetite
than high leptin levels, which are associated with leptin
resistance, as occurs with obesity [8].
Levels of ghrelin, a potent stimulator of appetite [23,24,25],
were higher in those with shorter sleep. Ghrelin levels are also
positively associated with hunger ratings [26], but decrease
with increased BMI (see Table 2). In one study, after 3 mo of
dietary supervision, a reduction in BMI of approximately 5%
was associated with a 12% increase in ghrelin and a 15%
decrease in leptin [27]. These changes, in participants of
similar BMI to our sample and presumably producing
increased appetite, are comparable to those observed with
sleep loss of 2–3 h/night. With sleep loss, however, relatively
high ghrelin and low leptin levels are associated with
increased BMI. These changes can be hypothesized to play a
contributory, rather than compensatory, role in the develop-
ment of overweight and obesity with sleep restriction.
Our ﬁndings are strengthened by the large and well-
characterized population-based sample, attention to bias and
confounding factors, and in-laboratory polysomnographic
data. The changes in hormones with sleep duration were
consistent and of signiﬁcant magnitude. They also represent
the ﬁrst demonstration of a correlation between peripheral
hormone levels and both self-reported (questionnaire and
diary data) and polysomnographically determined sleep
amounts in a general population sample. While these data
are more comprehensive than previous studies on this topic,
Figure 2. The Relationship between BMI and Average Nightly Sleep
Mean BMI and standard errors for 45-min intervals of average nightly
sleep after adjustment for age and sex. Average nightly sleep values
predicting lowest mean BMI are represented by the central group.
Average nightly sleep values outside the lowest and highest intervals
are included in those categories. Number of visits is indicated below
the standard error bars. Standard errors are adjusted for within-
subject correlation.
DOI: 10.1371/journal.pmed.0010062.g002
Table 2. Relationships among Metabolic Hormone Levels, Age, Sex and BMI
Variable (n) Age Sex (Female) BMI
Coefﬁcient
a p Coefﬁcient p Coefﬁcient p
Ghrelin
b (856) 0.015 0.67 3.71 ,0.001  0.10 0.01
Leptin
b (1,017) 0.0077 0.07 2.02 ,0.001 0.17 ,0.001
Adiponectin
b (1,015) 0.012 0.009 0.6 ,0.001  0.031 ,0.001
Insulin
c,d (936)  0.00092 0.65  0.13 ,0.001 0.046 ,0.001
Glucose
c,d (945) 0.0018 ,0.001  0.044 ,0.001 0.0068 ,0.001
QUICKI
d (901) 0.00011 0.43 0.0082 ,0.001  0.0029 ,0.001
Each row represents a single regression analysis.
a All models also included a term for time since sample was drawn (time of storage). A change of one unit of the predictor variables (age, female indicator) results in a change of the coefficient’s size and direction in the transformed variable.
b Square-root transformation used in these models.
c Natural logarithm transformation used in these models.
d Participants with diabetes were excluded (self-reported diagnosis, currently taking insulin or diabetic medications, or glucose .300 mg/dl).
DOI: 10.1371/journal.pmed.0010062.t002
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person variability or limitations of polysomnographic meas-
urement. Little is known about the stability of self-reported
sleep duration and polysomnographic measures of sleep
duration over time. We examined the stability of the self-
reported sleep duration data, and found these measures to be
stable. For 860 participants who completed three surveys, the
mean (standard deviation) of intra-person differences in
usual sleep for two 5-y periods was 0.10 (0.47) h. For 190
participants with at least three sleep diaries, the mean
(standard deviation) of intra-person differences in average
nightly sleep for two 4-y intervals was 0.09 (0.41) h.
Furthermore, the subjectively reported hours of usual sleep
and the diary-derived average nightly sleep values were highly
correlated (r=0.55, p , 0.001). One-night polysomno-
graphically deﬁned total sleep time had a similar intra-person
mean difference (0.10 h), with a somewhat larger standard
deviation (0.68) for 713 participants with at least three sleep
studies.
Elevated ghrelin mainly correlated with acute sleep loss as
measured by polysomnography immediately prior to blood
sampling (see Table 4; Figure 3B), while reduced leptin
correlated with chronic sleep restriction indicated by self-
reported sleep measures (see Table 4; Figure 3A). Measures of
usual and one-night polysomnographically deﬁned sleep time
were only weakly, but statistically signiﬁcantly, correlated (r
= 0.12, p , 0.001), supporting the concept that these
measures reﬂect long-term and short-term changes in sleep
amounts, respectively. Our ﬁndings are in agreement with the
current view that leptin is important in signaling long-term
nutritional status while ghrelin has a more signiﬁcant role in
acute hunger. The changes in leptin and ghrelin with sleep
restriction could, therefore, provide a powerful dual stimulus
to food intake that may culminate in obesity.
Longitudinal and intervention studies will be necessary to
deﬁne further the link between sleep curtailment and
increased BMI. Only total ghrelin was measured, since active
octanoylated ghrelin is unstable. Although both total and
active ghrelin appear to be regulated in a similar and parallel
manner, future studies will need to focus on measurement of
the biologically active form. Other potentially important
appetite regulatory hormones, such as PYY 3–36 [28], were
not measured. Measures of appetite were not included in the
Wisconsin Sleep Cohort Study overnight protocol; therefore,
a direct examination of the relationship between the
observed hormone changes with sleep duration and alter-
ations in appetite was not possible.
Hormone measurements were all performed on a single
Table 3. Partial Pearson Correlations of Metabolic Hormones and QUICKI after Adjustment for Sex, Age, and BMI
n=843
c Ghrelin
a Leptin
a Adiponectin
a Insulin
b
r (p value) r (p value) r (p value) r (p value)
Leptin  0.092 (0.007)
Adiponectin 0.081 (0.02) 0.050 (0.15)
Insulin  0.12 (,0.001) 0.32 (,0.001)  0.19 (,0.001)
QUICKI
d 0.11 (0.001)  0.26 (,0.001) 0.17 (,0.001)  0.84 (,0.001)
Shown are unstandardized correlation coefficients.
a Square-root transformation.
b Natural logarithm transformation.
c A total of 843 participants had data for all variables; correlations were calculated within this subset.
d QUICKI = 1/(log(I) þ log(G)) where I is fasting insulin and G is fasting glucose.
DOI: 10.1371/journal.pmed.0010062.t003
Table 4. Relationships between Sleep Variables and Metabolic Hormones, Adjusted for Age, Sex, BMI, and Time of Sample
Storage
Metabolic
Hormone
Sleep Efﬁciency
(Proportion)
Total Sleep Time
(Hours)
WASO (Hours) Average Nightly Sleep
(Hours)
Average Nightly Sleep
with Naps (Hours)
Usual Sleep
(Hours)
n
a Coefﬁcient p Coefﬁcient p Coefﬁcient pn Coefﬁcient pn Coefﬁcient pn Coefﬁcient p
Ghrelin
b 856  5.1 0.05  0.69 0.008 0.81 0.05 617  0.52 0.13 611  0.66 0.05 855  0.096 0.72
Leptin
b,c 1,017 0.15 0.62 0.047 0.13  0.041 0.40 716 0.11 0.01 709 0.12 0.006 1,015 0.089 0.006
Adiponectin
b 1,015 0.075 0.82  0.020 0.54  0.013 0.81 714 0.073 0.11 707 0.070 0.11 1,014 0.019 0.57
Insulin
d,e 936 0.091 0.55 0.024 0.12  0.018 0.47 659 0.016 0.44 652 0.012 0.55 936 0.020 0.22
Glucose
d,e 945 0.041 0.25 0.003 0.48  0.010 0.06 663 0.0071 0.17 656 0.0058 0.26 945 0.0051 0.18
QUICKI
e 901 0.0023 0.82  0.0012 0.25  0.0003 0.88 639  0.0012 0.42 632  0.0008 0.59 901  0.0011 0.34
Each coefficient is from a separate regression model. The first three sleep variables were derived from nighttime polysomnography data; average nightly sleep (with and without naps) was derived from sleep diary data, and usual sleep was
derived from questionnaire data.
a Sample sizes for all polysomnography-derived sleep variables (sleep efficiency, total sleep time, and WASO).
b Square-root transformation used in these models.
c Outliers excluded. One participant was removed from all models because of a very high leptin level and low BMI (21 kg/m
2). For the leptin/average nightly sleep and leptin/average nightly sleep with naps models, two participants were
removed: one was a large outlier (very high leptin level), and one had 6-d diary sleep of less than 12 h, which was influential. Removing these two points resulted in a slightly smaller, less significant coefficient. For the leptin/usual sleep model,
one outlier with a large leptin value was removed. Again, this resulted in a slightly smaller, less significant coefficient.
d Natural logarithm transformation used in these models
e Participants with diabetes were excluded (self-reported diagnosis, currently taking insulin or diabetic medications, or glucose .300 mg/dl, n =7 8 ) .
DOI: 10.1371/journal.pmed.0010062.t004
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Leptin, Ghrelin, and Sleepfasted, morning sample and may not reﬂect the 24-h proﬁle. It
is possible that participants with shorter sleep woke up earlier
and that hormone differences may be partially related to
circadian time. Leptin and ghrelin levels rise slightly during
the night [29], and this could result in higher hormone levels
in short sleepers. This may be an issue for ghrelin, as levels
increased with acute sleep restriction. It is, however, unlikely
to play a role in the leptin ﬁnding, since lower levels were
found with chronic but not acute sleep restriction. Addition-
ally, studies have shown a high correlation between morning,
fasting leptin and ghrelin levels and 24-h mean proﬁle [29,30].
We also found that the ghrelin and leptin changes were
unaffected by morningness tendencies. The fact that studies
investigating the diurnal proﬁle of these hormones found
similar hormonal changes over the entire 24-h period after
experimental sleep restriction also corroborates our results
[18,19]. The robustness of our ﬁndings and similar observa-
tions from smaller controlled studies [18,19] also suggest that
our statistically signiﬁcant results are unlikely to be a
reﬂection of the number of analyses carried out.
Animal studies have suggested a link between sleep and
metabolism [31,32]. In rats, prolonged, complete sleep
deprivation increased both food intake and energy expendi-
ture. The net effect was weight loss and, ultimately, death [33].
Rats fed a high protein-to-calorie diet had accelerated weight
loss, compared to sleep-deprived rats fed calorie-augmented
(fatty) diets [32]. Food consumption remained normal in
sleep-deprived rats fed protein-rich diets, but increased
250% in rats fed calorie-rich diets. Preference for fatty foods
has also been reported anecdotally in sleep-deprived humans
[32,34]. Sleep deprivation may thus increase not only appetite
but also preference for lipid-rich, high-calorie foods. Animal
experiments that have found weight loss after prolonged
sleep deprivation have to be interpreted in the context of a
stressful procedure producing intense sleep debt [35,36],
which may interfere with adequate food intake. From our
study, we hypothesize that the moderate chronic sleep debt
associated with habitual short sleep is associated with
increased appetite and energy expenditure. In societies
where high-calorie food is freely available and consumption
uncontrolled, after milder chronic sleep restriction, the
equation may be tipped towards food intake for high-calorie
food rather than expenditure, culminating in obesity. Short
sleepers may also have more time to overeat.
Sleep loss from a baseline of 7.7 h was associated with a
dose-dependent increase in BMI. This was the predominant
effect in a population increasingly curtailing sleep [37]. Sleep
greater than 7.7 h, however, was also associated with
increased BMI. Patients with SDB (a pathology associated
with increased BMI) may spend a longer time in bed to
compensate for fragmented sleep; however, controlling for
AHI did not change the curvilinear BMI–sleep association.
Another possibility is that in long sleepers, reduced energy
expenditure due to increased time in bed has a greater
impact than reduced food intake. In favor of this hypothesis,
long sleepers exercise less [38]. In our data, we found that the
odds ratio of high levels of self-reported exercise (.7 h/wk),
based on a single survey question, decreased with increased
sleep time, but controlling for this variable also did not
change our ﬁndings (analyses not shown).
Insulin resistance with sleep deprivation has been reported
in a laboratory study of young, healthy volunteers [39]. When
controlling for BMI, we found no signiﬁcant correlation
between insulin, glucose, or adiponectin levels and various
measures of sleep duration. Also, there was no signiﬁcant
correlation between QUICKI (or the homeostatic model
assessment HOMA [16]; data not shown) and sleep duration.
This may be due to difﬁculties in detecting small effects on
glucose tolerance under less-controlled conditions of large
population studies.
Our results demonstrate an important relationship be-
tween sleep and metabolic hormones. The direct effect of
chronic partial sleep loss on food intake, energy expenditure,
and obesity now needs to be explored. Altering sleep
duration may prove to be an important adjunct to preventing
and treating obesity.
Figure 3. The Association between Sleep Duration and Serum Leptin
and Ghrelin Levels
(A) Mean leptin levels and standard errors for half-hour increments
of average nightly sleep after adjustment for age, sex, BMI, and time
of storage (see Table 2). Average nightly sleep values outside the
lowest and highest intervals are included in those categories. Sample
sizes are given below the standard error bars. The y-axis uses a
square-root scale. Data derived from 718 diaries because three
participants had missing leptin data.
(B) Mean ghrelin levels and standard errors for half-hour increments
of total sleep time after adjustment for age, sex, BMI, and time of
storage (see Table 2). Total sleep time values outside the lowest and
highest intervals are included in those categories. The y-axis uses a
square-root scale. Note that ranges for total sleep time amounts are
typically shorter than those for average nightly sleep amounts (A; see
Figure 1), and do not correlate strongly (see text).
DOI: 10.1371/journal.pmed.0010062.g003
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Patient Summary
Why Was This Study Done? Recent studies have shown that there is a
link between sleeping less and gaining weight. It isn’t clear why there is
this link—perhaps, for example, those who are awake in the middle of
the night tend to head for the refrigerator for a snack. Another possibility
is that the amount of sleep that we have might affect the hormones that
control our appetite. We know that extreme sleep deprivation affects the
level of leptin, a hormone that controls appetite. Here, the researchers
wanted to study levels of leptin and other appetite hormones under
more normal conditions, in people with a range of sleeping habits.
What Did the Researchers Do? The researchers studied participants in a
large sleep study that has been going on in Wisconsin for over 15 years.
These participants have been filling out questionnaires about their sleep
habits and their health in general, have kept sleep diaries, and have
occasionally spent a night in the laboratory, where researchers studied
their sleep in more detail. After sleeping overnight in the laboratory, the
participants gave blood samples, which were tested for hormones.
What Did They Find? The researchers found that people who slept less
were on average heavier. And people who slept less had lower levels of
leptin and higher levels of ghrelin, another hormone that controls food
intake.
What Does This Mean? The combination of low leptin and high ghrelin
is likely to increase appetite. In other words, short sleep might stimulate
appetite, which increases weight.
What Next? Future studies need to examine the effect of regular short
sleeping hours on appetite, food intake, and obesity. These studies could
help to answer the question of whether the rise in obesity in many
societies is partly due to the fact that people are sleeping less. And it
seems well worth testing whether increasing sleep to seven or eight
hours per night could help people to lose weight.
Additional Online Information
National Sleep Foundation Web page on obesity and sleep: http://
www.sleepfoundation.org/features/obesity.cfm
World Federation of Sleep Research Societies: http://www.wfsrs.org/
homepage.html
Red en Medicina del Suen ˜o: http://www.rems.com.ar/
European Sleep Research Society: http://www.esrs.org/
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